NCT00768131 2015-10-28
A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel
Eli Lilly and Company
Phase 2 Withdrawn
Eli Lilly and Company
UNC Lineberger Comprehensive Cancer Center